EP3865140 - PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CLOSTRIDIUM DIFFICILE INFECTION [Right-click to bookmark this link] | |||
Former [2021/33] | <SMALLCAPS/>? ? ?CLOSTRIDIUM DIFFICILE? ? ? ? ?PREVENTIVE AND/OR THERAPEUTIC AGENT FORINFECTION | ||
[2022/19] | Status | The application has been withdrawn Status updated on 02.08.2024 Database last updated on 22.08.2024 | |
Former | Request for examination was made Status updated on 16.07.2021 | ||
Former | The international publication has been made Status updated on 18.04.2020 | Most recent event Tooltip | 02.08.2024 | Withdrawal of application | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Nutri Co., Ltd. 1-122 Fuji-cho Yokkaichi-shi Mie 510-0013 / JP | [2021/33] | Inventor(s) | 01 /
KAWAGUCHI, Susumu c/o Nutri Co., Ltd., 1-122, Fuji-cho Yokkaichi-shi, Mie 510-0013 / JP | 02 /
KATO, Miho c/o Nutri Co., Ltd., 1-122, Fuji-cho Yokkaichi-shi, Mie 510-0013 / JP | [2021/33] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2021/33] | Application number, filing date | 19870609.5 | 04.10.2019 | [2021/33] | WO2019JP39254 | Priority number, date | JP20180191488 | 10.10.2018 Original published format: JP 2018191488 | [2021/33] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020075637 | Date: | 16.04.2020 | Language: | JA | [2020/16] | Type: | A1 Application with search report | No.: | EP3865140 | Date: | 18.08.2021 | Language: | EN | [2021/33] | Type: | A8 Corrected patent application | No.: | EP3865140 | Date: | 18.05.2022 | [2022/20] | Search report(s) | International search report - published on: | JP | 16.04.2020 | (Supplementary) European search report - dispatched on: | EP | 07.10.2022 | Classification | IPC: | A61K35/744, A61P31/04, A23L33/135 | [2022/45] | CPC: |
A61P31/04 (EP,KR,US);
A61K35/744 (EP,KR,US);
A23L33/135 (EP,KR);
A61K9/0053 (US);
A23V2002/00 (KR);
A23V2200/324 (KR)
|
Former IPC [2021/33] | A61K35/744, A23L33/135, A61P31/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/33] | Title | German: | PRÄVENTIVES UND/ODER THERAPEUTISCHES MITTEL FÜR CLOSTRIDIUM DIFFICILE-INFEKTION | [2022/19] | English: | PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CLOSTRIDIUM DIFFICILE INFECTION | [2022/19] | French: | AGENT PRÉVENTIF ET/OU THÉRAPEUTIQUE POUR UNE INFECTION PAR CLOSTRIDIUM DIFFICILE | [2022/21] |
Former [2021/33] | <SMALLCAPS/>? ? ?CLOSTRIDIUM DIFFICILE? ? ? ? PROPHYLAKTIKUM UND/ODER THERAPEUTIKUM FÜR INFEKTION | ||
Former [2021/33] | <SMALLCAPS/>? ? ?CLOSTRIDIUM DIFFICILE? ? ? ? ?PREVENTIVE AND/OR THERAPEUTIC AGENT FORINFECTION | ||
Former [2021/33] | <SMALLCAPS/>? ? ?CLOSTRIDIUM? ? ? ? ?AGENT PROPHYLACTIQUE ET/OU THÉRAPEUTIQUE CONTRE LES INFECTIONS À <NS1:I> DIFFICILE</NS1:I> | Entry into regional phase | 10.05.2021 | Translation filed | 10.05.2021 | National basic fee paid | 10.05.2021 | Search fee paid | 10.05.2021 | Designation fee(s) paid | 10.05.2021 | Examination fee paid | Examination procedure | 10.05.2021 | Examination requested [2021/33] | 20.04.2023 | Amendment by applicant (claims and/or description) | 31.07.2024 | Application withdrawn by applicant [2024/36] | Fees paid | Renewal fee | 04.10.2021 | Renewal fee patent year 03 | 13.10.2022 | Renewal fee patent year 04 | 16.10.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US2016158295 (AFEYAN NOUBAR B [US], et al) [X] 1-3,6-9,12-15 * paragraphs [0084] - [0094] - [0097] - [0120] - [0191]; examples 1,8,10; claim 7 * [I] 1-15; | [XI] - MANSOUR NAHLA M ET AL, "Inhibition ofin Mice Using a Mixture of Potential Probiotic StrainsNM815,.NM915, andNM1015: Novel Candidates to ControlInfection (CDI)", PROBIOTICS AND ANTIMICROBIAL PROTEINS, NEW YORK, NY ; HEIDELBERG : SPRINGER, NEW YORK, NY ; HEIDELBERG : SPRINGER, vol. 10, no. 3, doi:10.1007/S12602-017-9285-7, ISSN 1867-1306, (20170511), pages 511 - 522, (20170511), XP037240333 [X] 1-3,6-8,11,12,15 * discussion * [I] 1-15 DOI: http://dx.doi.org/10.1007/s12602-017-9285-7 | International search | [Y]JP2002179580 (GU ZENWA, et al) [Y] 4* , experimental example 1 (Family: none) *; | [Y]JP2003261453 (NIPPON BERUMU KK) [Y] 4 * , claims, example 1 (Family: none) *; | [XY]JP2007320946 (ADVANCE CO LTD) [X] 1-3, 5-23 * , claims, paragraph [0002] (Family: none) * [Y] 4; | [Y]WO2018139503 (NUTRI CO LTD [JP]) [Y] 4 * , examples & AU 2018212041 A, examples & CA 3050675 A *; | [X] - Anonymous, "Relationship between Intestinal flora and lifestyle-related diseases and dietary habits [Industry Reportage "Intestinal Flora and Lifestyle-related Diseases" and Dietary Relationships--Latest Research Presented at Yakult Bioscience Research Foundation]", Food Industry, (20000000), vol. 44, no. 1 (975), ISSN 0559-8990, pages 26 - 29, XP009527685 [X] 1, 2, 5-23 | [X] - T. Yamamoto-Osaki, S. Kamiya, S. Sawamura, M. Kai, A. Ozawa, "Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture", Journal of Medical Microbiology, (19940000), vol. 40, doi:10.1099/00222615-40-3-179, ISSN 0022-2615, pages 179 - 187, XP055700799 [X] 1, 2, 5-23 * , abstract, fig. 1, 2 * DOI: http://dx.doi.org/10.1099/00222615-40-3-179 | by applicant | JP2018191488 | - "Basic science and clinical aspect of Clostridium difficile infection", Modern Media, vol. 56, no. 10, (20100000), URL: www.eiken.co.ip/modernmedia/backnumber/pdf/MM1010_01.pdf | - YAKUGAKU ZASSHI, (19920000), vol. 113, pages 396 - 399 | - Journal of Animal Clinical Research, (19940000), vol. 3, pages 11 - 20 |